| Literature DB >> 27076969 |
Cherry X Cheung1, Donagh A Healy1, Stewart R Walsh1.
Abstract
Remote ischaemic preconditioning (RIPC) is an attractive cardioprotective strategy. Although results from animal studies and phase II study on humans are convincing, it cannot have a role in clinical practice until benefits in clinical outcomes are proven in phase III study. Two phase III studies were recently published [Remote Ischemic Preconditioning for Heart Surgery (RIPHeart) and Effect of Remote Ischemic Preconditioning on Clinical Outcomes in Patients Undergoing Coronary Artery Bypass Surgery (ERICCA)] and this article discusses their design, results and implications.Entities:
Keywords: Remote preconditioning; cardiac surgery; cardioprotection
Year: 2016 PMID: 27076969 PMCID: PMC4805795 DOI: 10.21037/jtd.2016.01.81
Source DB: PubMed Journal: J Thorac Dis ISSN: 2072-1439 Impact factor: 2.895